Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitors
Identifieur interne : 001135 ( Main/Exploration ); précédent : 001134; suivant : 001136Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitors
Auteurs : Prabha Ranganathan [États-Unis]Source :
- Annals of the Rheumatic Diseases [ 0003-4967 ] ; 2013-05.
English descriptors
- Teeft :
- Adalimumab, Administrative databases, Anakinra, Antagonist, Antirheumatic, Antirheumatic drugs, Azathioprine, Biologic agents, Biologics, British society, Caplan, Chronic lung, Clin, Cohort, Common infections, Comorbidities, Cyclophosphamide, Database, Etanercept, February, Galloway, Herpes, Herpes zoster, Herpes zoster risk factors, Highest risk, Hydroxychloroquine, Injectable, Injectable gold, Interests none, Kidney disease, Letter herpes zoster infection risk, Lower risk, Mcdonald, Methotrexate, Moseley, National cohort, Nbdmards, Necrosis factor therapy, Older patients, Online, Peer review, Penicillamine, Prabha, Prabha ranganathan, Prabha ranganathan correspondence, Ranganathan, Reference group, Retrospective cohort study, Rheum, Rheumatoid, Rheumatoid arthritis, Rheumatologist, Rheumatology, Rheumatology biologics, Similar results, Soft tissue infections, Ssti, Sulfasalazine, Tumour, Tumour necrosis factor, Tumour necrosis factor inhibitors, Veterans affairs, Washington university school, Zeringue, Zoster.
Url:
DOI: 10.1136/annrheumdis-2013-203450
Affiliations:
- États-Unis
- Missouri (État)
- Saint-Louis (Missouri)
- École de médecine (Université Washington de Saint-Louis)
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001635
- to stream Istex, to step Curation: 001635
- to stream Istex, to step Checkpoint: 000187
- to stream Main, to step Merge: 001136
- to stream Main, to step Curation: 001135
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitors</title><author wicri:is="90%"><name sortKey="Ranganathan, Prabha" sort="Ranganathan, Prabha" uniqKey="Ranganathan P" first="Prabha" last="Ranganathan">Prabha Ranganathan</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:14628D076C0378C6084D4714070966AA4426429F</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1136/annrheumdis-2013-203450</idno><idno type="url">https://api.istex.fr/ark:/67375/NVC-3CJ9CMR5-K/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001635</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001635</idno><idno type="wicri:Area/Istex/Curation">001635</idno><idno type="wicri:Area/Istex/Checkpoint">000187</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000187</idno><idno type="wicri:doubleKey">0003-4967:2013:Ranganathan P:herpes:zoster:infection</idno><idno type="wicri:Area/Main/Merge">001136</idno><idno type="wicri:Area/Main/Curation">001135</idno><idno type="wicri:Area/Main/Exploration">001135</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitors</title><author wicri:is="90%"><name sortKey="Ranganathan, Prabha" sort="Ranganathan, Prabha" uniqKey="Ranganathan P" first="Prabha" last="Ranganathan">Prabha Ranganathan</name><affiliation wicri:level="4"><country wicri:rule="url">États-Unis</country><wicri:regionArea>Correspondence to Dr Prabha Ranganathan, Division of Rheumatology, Box 8045, Washington University School of Medicine, St. Louis 63110, MO</wicri:regionArea><placeName><region type="state">Missouri (État)</region><settlement type="city">Saint-Louis (Missouri)</settlement></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName></affiliation></author></analytic><monogr></monogr><series><title level="j">Annals of the Rheumatic Diseases</title><title level="j" type="abbrev">Ann Rheum Dis</title><idno type="ISSN">0003-4967</idno><idno type="eISSN">1468-2060</idno><imprint><publisher>BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><date type="published" when="2013-05">2013-05</date><biblScope unit="volume">72</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="4">e4</biblScope></imprint><idno type="ISSN">0003-4967</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0003-4967</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Adalimumab</term><term>Administrative databases</term><term>Anakinra</term><term>Antagonist</term><term>Antirheumatic</term><term>Antirheumatic drugs</term><term>Azathioprine</term><term>Biologic agents</term><term>Biologics</term><term>British society</term><term>Caplan</term><term>Chronic lung</term><term>Clin</term><term>Cohort</term><term>Common infections</term><term>Comorbidities</term><term>Cyclophosphamide</term><term>Database</term><term>Etanercept</term><term>February</term><term>Galloway</term><term>Herpes</term><term>Herpes zoster</term><term>Herpes zoster risk factors</term><term>Highest risk</term><term>Hydroxychloroquine</term><term>Injectable</term><term>Injectable gold</term><term>Interests none</term><term>Kidney disease</term><term>Letter herpes zoster infection risk</term><term>Lower risk</term><term>Mcdonald</term><term>Methotrexate</term><term>Moseley</term><term>National cohort</term><term>Nbdmards</term><term>Necrosis factor therapy</term><term>Older patients</term><term>Online</term><term>Peer review</term><term>Penicillamine</term><term>Prabha</term><term>Prabha ranganathan</term><term>Prabha ranganathan correspondence</term><term>Ranganathan</term><term>Reference group</term><term>Retrospective cohort study</term><term>Rheum</term><term>Rheumatoid</term><term>Rheumatoid arthritis</term><term>Rheumatologist</term><term>Rheumatology</term><term>Rheumatology biologics</term><term>Similar results</term><term>Soft tissue infections</term><term>Ssti</term><term>Sulfasalazine</term><term>Tumour</term><term>Tumour necrosis factor</term><term>Tumour necrosis factor inhibitors</term><term>Veterans affairs</term><term>Washington university school</term><term>Zeringue</term><term>Zoster</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Missouri (État)</li></region><settlement><li>Saint-Louis (Missouri)</li></settlement><orgName><li>École de médecine (Université Washington de Saint-Louis)</li></orgName></list><tree><country name="États-Unis"><region name="Missouri (État)"><name sortKey="Ranganathan, Prabha" sort="Ranganathan, Prabha" uniqKey="Ranganathan P" first="Prabha" last="Ranganathan">Prabha Ranganathan</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001135 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001135 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:14628D076C0378C6084D4714070966AA4426429F
|texte= Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitors
}}
| This area was generated with Dilib version V0.6.33. |  |